DK2174956T3 - Sammensætninger til anti-fibrinolytisk behandling - Google Patents

Sammensætninger til anti-fibrinolytisk behandling

Info

Publication number
DK2174956T3
DK2174956T3 DK08787634.8T DK08787634T DK2174956T3 DK 2174956 T3 DK2174956 T3 DK 2174956T3 DK 08787634 T DK08787634 T DK 08787634T DK 2174956 T3 DK2174956 T3 DK 2174956T3
Authority
DK
Denmark
Prior art keywords
compositions
fibrinolytic treatment
fibrinolytic
treatment
Prior art date
Application number
DK08787634.8T
Other languages
English (en)
Inventor
Lopategui Josune Orbe
Fernandez Jose Antonio Paramo
Garcia Jose Antonio Rodriguez
Vargas Rosario Serrano
Original Assignee
Proyecto Biomedicina Cima Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proyecto Biomedicina Cima Sl filed Critical Proyecto Biomedicina Cima Sl
Application granted granted Critical
Publication of DK2174956T3 publication Critical patent/DK2174956T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
DK08787634.8T 2007-06-26 2008-06-26 Sammensætninger til anti-fibrinolytisk behandling DK2174956T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200701786A ES2313841B1 (es) 2007-06-26 2007-06-26 Composiciones para tratamiento anti-fibrinolitico.
PCT/ES2008/000453 WO2009000957A1 (es) 2007-06-26 2008-06-26 Composiciones para tratamiento anti-fibrinolitico

Publications (1)

Publication Number Publication Date
DK2174956T3 true DK2174956T3 (da) 2012-10-01

Family

ID=40185221

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08787634.8T DK2174956T3 (da) 2007-06-26 2008-06-26 Sammensætninger til anti-fibrinolytisk behandling

Country Status (11)

Country Link
US (1) US8257701B2 (da)
EP (1) EP2174956B1 (da)
JP (1) JP2010531341A (da)
CN (1) CN101918441B (da)
AU (1) AU2008269686B8 (da)
BR (1) BRPI0813222A2 (da)
CA (1) CA2692986A1 (da)
DK (1) DK2174956T3 (da)
ES (2) ES2313841B1 (da)
RU (1) RU2453337C2 (da)
WO (1) WO2009000957A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009118660A2 (en) 2008-03-24 2009-10-01 Salman Rahman Adam-15 antibodies and immunogenic peptides
US9732157B2 (en) 2010-10-01 2017-08-15 Salman Rahman Methods for the development of metzincin-selective catalytic cleft directed antibodies for therapeutic and diagnostic applications
WO2015107139A1 (en) * 2014-01-17 2015-07-23 Proyecto De Biomedicina Cima, S.L. Compounds for use as antifibrinolytic agents
RU2657756C2 (ru) * 2016-08-30 2018-06-15 Общество с ограниченной ответственностью "ПРОФИТ ФАРМ" Способ лечения кровотечений из верхних отделов желудочно-кишечного тракта
US11654057B2 (en) 2020-04-09 2023-05-23 Bio 54, Llc Devices for bleeding reduction and methods of making and using the same
US11642324B1 (en) 2022-03-01 2023-05-09 Bio 54, Llc Topical tranexamic acid compositions and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830468A (en) * 1995-05-17 1998-11-03 The New York Blood Center, Inc. Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase
AU756150C (en) * 1997-11-14 2004-03-04 G.D. Searle & Co. Aromatic sulfone hydroxamic acid metalloprotease inhibitor
JPH11318449A (ja) * 1998-03-10 1999-11-24 Fuji Chem Ind Ltd ストロメライシン―２（ｍｍｐ―１０）に対する抗体
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
IL132558A0 (en) * 1999-10-25 2001-03-19 Compugen Ltd Variants of alterntive splicing
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
RU2010102090A (ru) 2011-08-10
CA2692986A1 (en) 2008-12-31
EP2174956A1 (en) 2010-04-14
JP2010531341A (ja) 2010-09-24
US20100135986A1 (en) 2010-06-03
EP2174956A4 (en) 2011-05-25
CN101918441B (zh) 2013-06-19
AU2008269686B8 (en) 2013-02-14
RU2453337C2 (ru) 2012-06-20
US8257701B2 (en) 2012-09-04
ES2313841A1 (es) 2009-03-01
BRPI0813222A2 (pt) 2014-12-23
WO2009000957A1 (es) 2008-12-31
CN101918441A (zh) 2010-12-15
ES2390391T3 (es) 2012-11-12
AU2008269686B2 (en) 2013-01-10
EP2174956B1 (en) 2012-06-27
AU2008269686A1 (en) 2008-12-31
ES2313841B1 (es) 2010-01-12

Similar Documents

Publication Publication Date Title
BRPI0810634A2 (pt) Composições fungicidas
DK2061561T3 (da) Sammensætninger til behandling af cancer
DK2634232T3 (da) Sammensætninger
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
DK2214679T3 (da) Kortikosteroidsammensætninger
BRPI1011587A2 (pt) compostos e composições terapèuticas
BRPI0813775A2 (pt) Composição
DE602008002756D1 (de) Bauzusammensetzung
BRPI0919708A2 (pt) composições antimicrobianas
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
RU2493831C3 (ru) Фармацевтические композиции
ES2628203T8 (es) Composiciones antitranspirantes
BRPI0914427B8 (pt) composição dental endurecível
BRPI0917231A2 (pt) composição
FR2933868B1 (fr) Compositions cosmetiques
BRPI0722002A2 (pt) composições de desodorante
BRPI0821907A2 (pt) Composições de siloxano
BRPI0810557A2 (pt) composição
BRPI0913437A2 (pt) composições de cloreto estanhoso
BRPI0812592A2 (pt) Composição assada
DK3300729T3 (da) Terapeutiske sammensætninger indeholdende macitentan
BRPI0811274A2 (pt) Composição
BRPI0921705A2 (pt) Composições antimicrobianas
BRPI0915427A2 (pt) composição farmacêutica